DiscoverThe Rounds TableEpisode 87 - The ULTIMATE-DAPT Trial and Empagliflozin after Acute Myocardial Infarction
Episode 87 - The ULTIMATE-DAPT Trial and Empagliflozin after Acute Myocardial Infarction

Episode 87 - The ULTIMATE-DAPT Trial and Empagliflozin after Acute Myocardial Infarction

Update: 2024-06-06
Share

Description

Welcome back Rounds Table Listeners!

We are back today with our Classic Rapid Fire Podcast!

This week, Drs. Mike and John Fralick discuss two recent papers exploring the role of ticagrelor with aspirin versus ticagrelor alone after percutaneous coronary intervention in acute MI and the efficacy of empagliflozin after acute MI. Two papers, here we go!

  1. Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT) (0:009:22 ).
  2.  Empagliflozin after Acute Myocardial Infarction (9:2216:00 ).

And for the Good Stuff:

Questions? Comments? Feedback? We’d love to hear from you! @roundstable

Comments 
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Episode 87 - The ULTIMATE-DAPT Trial and Empagliflozin after Acute Myocardial Infarction

Episode 87 - The ULTIMATE-DAPT Trial and Empagliflozin after Acute Myocardial Infarction

Dr. John Fralick and Dr. Michael Fralick